Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Oct 27 - Nov 1
Dihexa's effects are tied to the HGF/c-Met system hepatocyte growth factor and its receptor which plays a central role in synaptogenesis, the formation of new synapses
Regulatory Status of KLOW Components in Canada Health Canada Regulatory Status of Each Component None of the four peptides in KLOW (BPC-157, GHK-Cu, TB-500, or KPV) is an authorized health product in Canada
Shake well before opening
more reliable absorption than oral Challenge: Requires injection, carries infection risk if not sterile Bioavailability: Likely higher than oral but lower than intravenous Practical consideration: Not widely used in the community
TB-500 offers similar but distinct healing properties, particularly for muscle tissue and flexibility
Gmez-Virgilio L, Silva-Lucero M-C, Flores-Morelos D-S, Gallardo-Nieto J, Lopez-Toledo G, Abarca-Fernandez A-M, Zacapala-Gmez A-E, Luna-Muoz J, Montiel-Sosa F, Soto-Rojas LO, Pacheco-Herrero M, Cardenas-Aguayo M-C
US$ 25.39
US$ 26.98
US$ 24.49
US$ 27.56
US$ 29.63
01053-X/asset/68ad1d8b-bb7e-4ca0-8f89-99384d885ca3/main.assets/gr2.jpg)
